Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):422-7. doi: 10.1016/j.bbrc.2010.11.047. Epub 2010 Nov 17.
HIV-1 Nef is a key factor for pathogenesis and is known to down-regulate functionally important molecules, including viral entry co-receptor CCR5 and CXCR4, from the surface of HIV-infected cells. Some of these Nef activities are mediated by the well-conserved proline-rich region of Nef, and this region is highly targeted by cytotoxic T lymphocytes (CTLs). In the present study, we asked whether Nef variants selected under CTL-mediated selective pressure in vivo may constrain these important Nef activities. The analysis of autologous nef sequences isolated from a cohort of total 235 subjects in Japan revealed that the subjects showing amino acid variations, such as Arg75Thr and Tyr85Phe, located within the proline-rich region were significantly over-represented by those having HLA-B*3501. CTL assays corroborated that these mutations conferred escape from HLA-B(∗)3501-restricted CTLs. The Arg75Thr variant Nef selectively impaired CCR5, but not CXCR4, down-regulation activity from the cell surface; whereas the Tyr85Phe variant Nef affected neither CCR5 nor CXCR4 down-regulation activity. Moreover, the cells expressing the Arg75Thr variant Nef significantly impaired protection from superinfection by CCR5-tropic, but not CXCR4-tropic, viruses. These results highlighted the importance of certain Nef-specific CTLs in modulation of viral co-receptor down-regulation activity and protection from HIV-1 superinfection, providing us with additional insight into vaccine design.
HIV-1 Nef 是发病机制的关键因素,已知它下调功能性重要分子,包括 HIV 感染细胞表面的病毒进入共受体 CCR5 和 CXCR4。Nef 的一些这些活性由 Nef 中高度保守的脯氨酸丰富区域介导,并且该区域是细胞毒性 T 淋巴细胞(CTL)的高度靶向目标。在本研究中,我们询问了在体内 CTL 介导的选择压力下选择的 Nef 变体是否可能限制这些重要的 Nef 活性。对来自日本的总共 235 名受试者的自体 nef 序列的分析表明,与 HLA-B*3501 相比,在脯氨酸丰富区域中显示氨基酸变化(如 Arg75Thr 和 Tyr85Phe)的受试者明显过多。CTL 测定证实这些突变赋予了对 HLA-B(∗)3501 限制的 CTL 的逃逸。Arg75Thr 变体 Nef 选择性地损害 CCR5,但不损害 CXCR4,从细胞表面下调活性;而 Tyr85Phe 变体 Nef 既不影响 CCR5 也不影响 CXCR4 下调活性。此外,表达 Arg75Thr 变体 Nef 的细胞显著削弱了对 CCR5 嗜性而不是 CXCR4 嗜性病毒的再次感染的保护。这些结果强调了某些 Nef 特异性 CTL 在调节病毒共受体下调活性和防止 HIV-1 再次感染中的重要性,为我们提供了对疫苗设计的更多见解。